XML 29 R18.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Stockholders’ Equity
 6 Months Ended
Jun. 30, 2024
Equity [Abstract]  
Stockholders’ Equity

10. Stockholders’ Equity

 

Common Stock

 

As of June 30, 2024, 4,230,806 shares of common stock were issued and outstanding, 255,958 shares of common stock were reserved for issuance upon the exercise of outstanding warrants, 612,952 shares of common stock were reserved for issuance under our 2015 and 2025 Equity Incentive Plans, as amended (the “2015 Plan” and “2025 Plan”), and 150,000 shares were reserved for issuance under our 2023 Non-Employee Director Compensation Plan.

 

The following table describes the shares and warrants issued as part of our 2022 and 2020 private placements:

 

Issuance of Common Stock  Issue Date 

Shares

Issued

  

Price per

share

  

Warrants

Issued

  

Warrant

Exercise

Price

  

Warrant

Fair

Value

 
Private Placement 2022  April 1, 2022   1,242,588   $4.62    124,258   $4.62   $3.91 
Private Placement 2020  March 2, 2020   955,000   $4.00    95,500   $4.00   $3.90 

 

Amortization of the debt issuance costs for the Private Placement 2022 offering was recorded at $33,936 and $94,531 for the three and six months ended June 30, 2024, and at $6,224 and $17,290 for the three and six months ended June 30, 2023.

 

Warrants

 

The following sets forth the warrants to purchase our common stock that were outstanding as of June 30, 2024:

 

Warrants

Outstanding

 

Warrant

Exercise Price

   Warranty Expiry
124,258  $4.62   March 30, 2027
95,500  $4.00   March 30, 2027
16,000  $9.00   March 30, 2027
17,200  $12.50   March 30, 2027
3,000  $15.00   March 30, 2027